- Home
- » Tags
- » Gemifloxacin
Top View
- Gemifloxacin; a Distinctive Quinolone Or a By-Passer Jamal Wadi Al Ramahi M.D
- Gemifloxacin Inhibits Cytokine Secretion by Lipopolysaccharide
- (Gemifloxacin Mesylate) Tablets WARNING: Fluoroquinolones
- Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01
- 2016 BSC Antibiotics.Pptx
- The Design and Synthesis of Novel Antimicrobial Agents for Use in the Battle Against Bacterial Resistance
- Antibiotic Streamlining
- Recommendations for Anti-Microbial Use for Secondary Infections in Patients with COVID-19 Rapid Review
- Mycobacterium Tuberculosis DNA Gyrase As a Target for Drug Discovery
- Fluoroquinolones, Oral Review 04/24/2008
- Antibiotic Research Tools
- Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects Against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains
- Systemic Fluoroquinolones – Conversion to Levofloxacin
- Pharmaabkommen A1 E
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- The Incidence of Collagen-Associated Adverse Events In
- FACTIVE (Gemifloxacin Mesylate) Is a Synthetic Broad-Spectrum Antibacterial Agent for Oral Administration
- Gemifloxacin
- Reptb: a Gene Ontology Based Drug Repurposing Approach for Tuberculosis Anurag Passi1,2, Neeraj Kumar Rajput1, David J
- Infectious Diseases, 3D Edition Elsevier/Mosby, 2010 Available on Line At
- A Novel Predictive Model for the Anti-Bacterial, Anti-Malarial and Herg Cardiac QT Prolongation Properties of Fluoroquinolones Clifford Fong
- Quinolones and Fluoroquinolones Art. 31
- Surveillance of Healthcare-Associated Infections and Prevention Indicators in European Intensive Care Units HAI-Net ICU Protocol, Version 2.2
- Quinolones and Their Clinical Relevance in the Management of Enteric Fevers in the New Millennium: Findings from a Review of 55,853 Salmonella Isolates
- The Use of Systemic and Topical Fluoroquinolones Abstract
- Critically Important Antimicrobials for Human Medicine, 6Th Revision
- Old Drugs for Newly Emerging Viral Disease, COVID-19: Bioinformatic Prospective
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- Quinolones a Systematic Quest
- Fluoroquinolones, Oral Therapeutic Class Review (TCR) June 18, 2013 Please Note: This Clinical Document Has Been Retired
- Critically Important Antimicrobials for Human Medicine
- Protein Synthesis and Nucleic Acid Synthesis Inhibitors
- Fluoroquinolones: State State of the the Art and Future Future Needs
- ARPEC Protocol for Drug Utilization Study
- FDA Requires Label Changes to Warn of Risk for Possibly Permanent Nerve Damage from Antibacterial Fluoroquinolone Drugs Taken by Mouth Or by Injection
- Antibiotic Use and Resistance in Food Animals Current Policy and Recommendations © Center for Disease Dynamics, Economics & Policy, 2016
- Quinolone Synthesis